Adamis Pharma Executives
Adamis Pharma employs about 11 people. The company is managed by 7 executives with a total tenure of roughly 49 years, averaging almost 7.0 years of service per executive, having 1.57 employees per reported executive. Discussion of Adamis Pharma's management performance can provide insight into the enterprise performance.
| Robert Rothermel Chairman Consultant, Director, Chairman of Audit Committee, Member of Nominating and Governance Committee and Member of Compensation Committee |
Adamis |
Adamis Pharma Management Team Effectiveness
The company has return on total asset (ROA) of (1.045) % which means that it has lost $1.045 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.8496) %, meaning that it created substantial loss on money invested by shareholders. Adamis Pharma's management efficiency ratios could be used to measure how well Adamis Pharma manages its routine affairs as well as how well it operates its assets and liabilities.Adamis Pharma Workforce Comparison
Adamis Pharma is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 24,062. Adamis Pharma adds roughly 11.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Adamis Pharma Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Adamis Pharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on Adamis Pharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Adamis Pharma insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Versi Ebrahim over a year ago Acquisition by Versi Ebrahim of 8745 shares of Adamis Pharma subject to Rule 16b-3 | ||
Richard Williams over a year ago Acquisition by Richard Williams of 50000 shares of Adamis Pharma subject to Rule 16b-3 |
Adamis Pharma Notable Stakeholders
An Adamis Pharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Adamis Pharma often face trade-offs trying to please all of them. Adamis Pharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Adamis Pharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Robert Rothermel | Consultant, Director, Chairman of Audit Committee, Member of Nominating and Governance Committee and Member of Compensation Committee | Profile | |
| David Marguglio | Sr. VP of Corporate Devel. and Director | Profile | |
| Karen Daniels | VP of Operations | Profile | |
| Jennifer Suski | Director Marketing | Profile | |
| Eddie Glover | Chief Inc | Profile | |
| Mark Flather | IR Contact Officer | Profile | |
| David Benedicto | Chief Officer | Profile |
Adamis Pharma Workforce Analysis
Traditionally, organizations such as Adamis Pharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Adamis Pharma within its industry.Adamis Pharma Manpower Efficiency
Return on Adamis Pharma Manpower
| Revenue Per Employee | 432.4K | |
| Revenue Per Executive | 679.4K | |
| Net Loss Per Employee | 2.4M | |
| Net Loss Per Executive | 3.8M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in Adamis Stock
If you are still planning to invest in Adamis Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adamis Pharma's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |